ArticleInternational journal of cancer2025
Reply to: "Comments on the paper 'Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple-negative breast cancer' by Y. Chen et al."
Youdinghuan Chen, Lucas A Salas, Jonathan D Marotti, Nicole P Jenkins, Chao Cheng, Todd W Miller, Arminja N Kettenbach, Brock C Christensen
Abstract readLetter
In one paragraphArticle in International journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Lucas A SalasDepartment of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
Jonathan D MarottiDepartment of Pathology and Laboratory Medicine, Dartmouth Medical Center, Lebanon, New Hampshire, USA.
Nicole P JenkinsDepartment of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
Todd W MillerDepartment of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
Arminja N KettenbachDepartment of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
Brock C ChristensenDepartment of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
Funding
Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3MPilot Project ProgramP30GM149408 · NIGMS · DARTMOUTH COLLEGE · PI MARGARET Rita KARAGAS · 2023 to 2026
$6.3MA precision medicine basis for estrogen therapy for advanced breast cancerR01CA200994 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Todd W. Miller · 2017 to 2026
$3.7MDNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to ImmunotherapyR01CA253976 · NCI · BROWN UNIVERSITY · PI CHRISTENSEN, BROCK C, KELSEY, KARL TIMOTHY · 2021 to 2025
$3.3MUncovering the basis and implications of lineage plasticity in breast cancerR01CA267691 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Todd W. Miller · 2022 to 2026
$1.8MBurroughs-Wellcome Big Data in Life Sciences Research FellowshipDartmouth Cancer Center Prouty Pilot Project FundingNCI NIH HHS P30 CA023108NCI NIH HHS P30CA023108NCI NIH HHS R01 CA200994NCI NIH HHS R01 CA253976NCI NIH HHS R01 CA267691NIGMS NIH HHS P30 GM149408NIH HHS P30GM149408NIH HHS R01CA200994NIH HHS R01CA253976NIH HHS R01CA267691Norris Cotton Cancer CenterWellcome Trust
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID40474572
PMCPMC12143072
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390